Prof Judy de Haan is a Baker Fellow (2017–2022) and Head of the Cardiovascular Inflammation and Redox Biology (CIRB) Laboratory at the Baker Heart & Diabetes Institute, Melbourne, Australia. She holds multiple honorary and adjunct appointments, including Honorary Professor at Swinburne and La Trobe Universities. She is an elected member of the Australian Cardiovascular Alliance Drug Discovery Flagship (2019–ongoing) and the International Atherosclerosis Federation Asia-Pacific Region (2025-). She is the immediate Past President (2026) of the Australian Atherosclerosis Society and President-Elect of the Society for Redox Research Australasia (2025–2026). Her research focuses on improving the lives of people with diabetes by reducing the burden of cardiovascular disease. Her work identifies novel therapies that target oxidative stress inflammation, and immunometabolism, opening new avenues for drug discovery. These pre-clinical studies are critical for understanding and addressing complications associated with diabetes, particularly in the context of the rising global obesity epidemic and its strong link to Type 2 Diabetes. Prof de Haan has published ~100 papers in leading journals: Circulation, Diabetes, Nature Immunology, Human Molecular Genetics, ATVB, Kidney International and JBC, with an H-index of 51 and >8200 citations. Her work is supported by numerous grants including 2 Australian NHMRC Ideas grants.